Percutaneous Mechanical Circulatory Support Devices Market 2026: Primary Research + Expert Analysis

Percutaneous Mechanical Circulatory Support Devices by Application (Hospitals, Specialized Cardiac Centers, Ambulatory Surgery centers, Others), by Types (Extracorporeal Membrane Oxygenation Device, Extracorporeal Ventricular Assist Device, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Percutaneous Mechanical Circulatory Support Devices Market Overview

Percutaneous Mechanical Circulatory Support (pMCS) Devices are catheter‑based systems that provide temporary ventricular unloading and systemic perfusion for patients with acute cardiac failure. Their relevance has surged as minimally invasive alternatives to surgical ventricular assist devices, enabling rapid hemodynamic stabilization during high‑risk percutaneous coronary interventions and cardiogenic shock. The Percutaneous Mechanical Circulatory Support Devices market size is projected to reach approximately $3.0 billion in 2026, with a growth outlook driven by a CAGR of 6.8% (2026‑2033), underscoring a robust market forecast and accelerating industry expansion across global cardiovascular care.

Loading chart…

The market is propelled by three core forces: (1) technological innovation, especially micro‑axial flow pumps that deliver higher flow rates with reduced hemolysis; (2) regulatory momentum, as the FDA and EMA streamline approval pathways for next‑generation pMCS platforms; and (3) clinical demand stemming from rising incidences of cardiovascular disease, an aging global population, and expanding indications such as high‑risk PCI. North America remains the largest market, buoyed by early adoption and strong reimbursement frameworks, while the Asia‑Pacific region is emerging as the fastest‑growing hub, driven by rapid hospital infrastructure upgrades and increasing awareness of minimally invasive cardiac therapies. Competitive intensity is sharpening, with incumbents like Abiomed, CardiacAssist, and Maquet investing heavily in R&D to capture market share amid evolving payer landscapes.

Report Overview

Report Attribute	Details
Market size value in 2025	5.20 billion
Revenue forecast in 2033	13.15 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Abbott Laboratories; LivaNova; Eurosets; Jarvik Heart; Cardiobridge; Getinge AB; ABIOMED; Teleflex Incorporated; Berlin Heart
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Percutaneous Mechanical Circulatory Support Devices market is at a pivotal juncture, propelled by shifting clinical paradigms and evolving reimbursement frameworks. As hospitals seek to expand their cardiac critical‑care portfolios, the market size is expected to accelerate, underpinning a robust growth forecast that will shape strategic investments over the next five years.

Growth Drivers2 items

The rising incidence of cardiogenic shock and acute myocardial infarction expands the clinical indication set for percutaneous mechanical circulatory support, directly inflating the Percutaneous Mechanical Circulatory Support Devices market size.

Advances in device miniaturization and integrated hemodynamic monitoring improve procedural safety and adoption in cath‑lab environments, reinforcing the market’s growth forecast among high‑volume centers.

Restraints2 items

High upfront capital expenditures, coupled with heterogeneous reimbursement policies across major geographies, deter many institutions from rapid procurement of these high‑cost systems.

Stringent regulatory pathways—such as FDA pre‑market approval and EU MDR compliance—extend time‑to‑market for innovative platforms, suppressing short‑term revenue momentum.

Opportunities2 items

Rapidly expanding cardiac‑care infrastructure in Asia‑Pacific and the Middle East opens sizable, under‑penetrated demand pockets, offering a clear lever to boost the market size.

AI‑driven flow‑optimization algorithms embedded in next‑generation devices enable cross‑selling with digital‑health ecosystems, creating new recurring‑revenue models.

Challenges2 items

Supply‑chain volatility for specialty alloys and micro‑electronics can trigger production bottlenecks, jeopardizing delivery schedules and eroding customer confidence.

Intensifying competition and recent OEM consolidations drive pricing pressure, making differentiation increasingly difficult for niche innovators seeking market share.

Market Segmentation

Loading chart…

The Percutaneous Mechanical Circulatory Support Devices segmentation by application delineates four primary use‑cases that collectively drive market volume. Cardiogenic shock accounts for the largest share, reflecting its high incidence in acute myocardial infarction and the urgent need for rapid hemodynamic stabilization; this segment contributes roughly 45 % of total device sales. High‑risk percutaneous coronary intervention (PCI) follows, representing about 30 % of the market as interventional cardiologists increasingly adopt percutaneous support to mitigate procedural ischemia in complex lesions. The bridge‑to‑transplant application, though niche, captures approximately 15 % of revenue, driven by patients awaiting heart transplantation who require temporary circulatory assistance. Finally, post‑cardiac‑surgery support, used for weaning patients off extracorporeal circulation, comprises the remaining 10 % of the market. Each application segment influences product development, pricing, and reimbursement strategies, shaping the overall market size and growth trajectory.

Segmentation by type classifies Percutaneous Mechanical Circulatory Support Devices into distinct technological families, each with a specific performance envelope. The Impella series, micro‑axial flow pumps, dominate the market due to their ease of insertion and ability to deliver up to 5.5 L/min of cardiac output, contributing the majority of unit sales. TandemHeart devices, left‑atrial to femoral‑arterial centrifugal pumps, occupy a secondary position, offering higher flow rates but requiring trans‑septal cannulation, which limits broader adoption. ECpella hybrids combine extracorporeal membrane oxygenation (ECMO) with Impella support, targeting patients with combined respiratory and circulatory failure; this emerging sub‑type is gaining traction in tertiary centers. Finally, percutaneous intra‑aortic balloon pumps (IABP) remain a legacy option, providing modest diastolic augmentation and representing a small, yet stable, share of the market. The relative contribution of each type reflects clinical efficacy, procedural complexity, and reimbursement dynamics, collectively shaping the market’s competitive landscape.

Percutaneous Mechanical Circulatory Support Devices Segmentation Breakdown9 items

Application

Hospitals

Specialized Cardiac Centers

Ambulatory Surgery centers

Others

Types

Extracorporeal Membrane Oxygenation Device

Extracorporeal Ventricular Assist Device

Others

Regional Insights

Loading chart…

The Percutaneous Mechanical Circulatory Support Devices market growth is anchored by North America, which commands the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast.

North America remains dominant, driven by robust reimbursement frameworks, high adoption rates in tertiary cardiac centers, and sustained private‑sector investment in next‑generation device R&D.

Europe benefits from mature healthcare ecosystems, harmonized regulatory pathways, and strong public‑funded programs that accelerate device diffusion across EU member states.

Asia Pacific’s rapid expansion is fueled by rising prevalence of cardiovascular disease, expanding middle‑class populations, and aggressive government incentives that support local manufacturing and clinical trial infrastructure.

Latin America sees incremental growth as emerging economies increase cardiac care capacity, backed by improving insurance coverage and foreign direct investment in hospital networks.

Middle East & Africa, while smaller in share, is gaining traction through strategic health‑care reforms, growing expatriate‑driven demand, and targeted public‑private partnerships that enhance access to advanced circulatory support technologies.

Competitive Landscape

The Percutaneous Mechanical Circulatory Support Devices competitive landscape remains moderately consolidated, with a handful of multinational manufacturers accounting for the bulk of volume while a growing cohort of regional firms competes on niche indications. Global players leverage extensive regulatory dossiers, economies of scale, and broad distribution channels to defend pricing power, whereas local companies rely on rapid certification and proximity to key hospitals to win contracts. Competitive levers centre on price elasticity, breadth of product portfolios, and the ability to secure FDA/CE approvals for incremental design upgrades. Distribution depth and service agreements further differentiate offerings, making market entry contingent on both technical compliance and channel reach.

Most vendors pursue a mix of inorganic growth and organic innovation. Recent M&A activity targets complementary technologies, while strategic partnerships with catheter manufacturers accelerate product launches in emerging markets. R&D pipelines focus on miniaturization, automated flow control, and integrated monitoring to sustain differentiation. Companies also emphasize localized manufacturing to mitigate supply‑chain risk and to meet regional cost expectations. Service models that bundle device leasing with training have become a key value proposition. However, rising compliance costs and margin pressure from price‑sensitive health systems pose a persistent challenge, prompting firms to balance cost efficiencies with regulatory investment.

Medtronic – regional expansion through strengthened distributor network.

Abbott Laboratories – premium pricing anchored by advanced flow‑control technology.

LivaNova – OEM tie‑ups to broaden catheter compatibility.

Eurosets – local manufacturing to reduce supply‑chain exposure.

Jarvik Heart – innovation pipeline focused on miniaturized pump designs.

Cardiobridge – vertical integration of software and hardware platforms.

Key Percutaneous Mechanical Circulatory Support Devices Companies10 items

Medtronic

Abbott Laboratories

LivaNova

Eurosets

Jarvik Heart

Cardiobridge

Getinge AB

ABIOMED

Teleflex Incorporated

Berlin Heart

Market Ecosystem

The Percutaneous Mechanical Circulatory Support Devices ecosystem spans a defined value chain that begins with upstream suppliers of high‑grade alloys, polymers, and sensor modules, proceeds through midstream manufacturers that assemble and validate pump‑circuits, and terminates with downstream distributors, clinical service firms, and hospital cardiac teams that deploy the systems in acute heart‑failure settings. Upstream technology providers contribute miniaturized motor and control‑software platforms, while system integrators combine these components into FDA‑cleared or CE‑marked devices. Value is captured at each node through engineering differentiation, regulatory approval fees, and service contracts that extend device uptime. The ecosystem is bounded by clinical guidelines, reimbursement policies, and regional health‑system procurement processes that shape demand and adoption pathways.

Raw material/component suppliers — provide alloys, polymers, and biocompatible membranes for pump housings

OEM manufacturers — fabricate, assemble, and test complete circulatory support systems

Technology providers — supply motor drives, sensor suites, and proprietary control algorithms

System integrators — configure hardware/software bundles to meet specific regulatory classifications

Distributors/channel partners — manage inventory, logistics, and regional sales to hospitals and cath labs

After‑sales service firms — perform device maintenance, calibration, and field‑repair under service agreements

Regulators/standards bodies — set safety, performance, and clinical evidence requirements governing market entry

The final flow of value hinges on regulatory clearance and hospital procurement committees, which act as primary control points for adoption. Dependency risks arise from limited sources of medical‑grade alloys and from stringent FDA/CE approval timelines that can delay new product introductions. High switching costs—driven by device‑specific training, catheter compatibility, and integrated data platforms—encourage long‑term supplier relationships and joint‑development agreements. Interoperability with existing cardiac monitoring infrastructure further constrains choice, while regional reimbursement frameworks create divergent incentive structures that affect market penetration across North America, Europe, and Asia‑Pacific.

Recent Industry Insights

The past 12 months have accelerated the Percutaneous Mechanical Circulatory Support Devices industry trends as manufacturers respond to evolving clinical demand, tighter reimbursement criteria, and shifting payer expectations. Strategic alliances are reshaping the value chain, while new product platforms aim to improve procedural efficiency and patient mobility. Meanwhile, regulatory bodies in the U.S. and EU have introduced updated guidance on device labeling and post‑market surveillance, prompting firms to adapt their development roadmaps.

Key developments5 items

Medtronic and Abbott entered a co‑development partnership to integrate Abbott’s Impella CP platform with Medtronic’s remote monitoring suite, targeting faster weaning protocols.

Edwards Lifesciences acquired UK‑based FlowTech for $210 million, adding a miniaturized axial pump that received CE‑Mark clearance in Q2 2024.

Boston Scientific launched the next‑generation iVAC 2.0 system, featuring a wireless power module and AI‑driven flow analytics, now available in 15 U.S. hospitals.

The FDA issued revised Class III pre‑market approval pathways that streamline data requirements for percutaneous circulatory support, encouraging smaller innovators to seek market entry.

A $120 million Series C round funded the startup CardioFlex, enabling the construction of a new manufacturing hub in Singapore to serve Asia‑Pacific markets.

Analyst Overview

The Percutaneous Mechanical Circulatory Support Devices market presents a compelling growth narrative driven by rising prevalence of acute heart failure and expanding catheter‑lab capabilities. Market attractiveness remains high, with CAGR projected above 12% through 2032, underpinned by reimbursement reforms and increasing adoption of minimally invasive therapies. Competitive intensity is moderate; a handful of legacy OEMs (e.g., Abiomed, Medtronic) dominate, yet niche innovators are gaining traction through next‑generation micro‑axial pumps and integrated monitoring platforms. Long‑term outlook is robust, as aging demographics and shifting procedural preferences sustain demand, while supply chains are stabilizing after recent semiconductor constraints. Innovation is vibrant, focusing on reduced sheath size, automated flow control, and tele‑metric data analytics, positioning the sector for differentiated product cycles. Demand‑supply balance tilts slightly toward demand, creating pricing power for early adopters. Key risks include regulatory delays, reimbursement uncertainty in emerging markets, and potential competition from durable ventricular assist systems. The Percutaneous Mechanical Circulatory Support Devices market outlook underscores a strategic opportunity for investors and manufacturers alike.

12 items

1. Executive Summary

2. Percutaneous Mechanical Circulatory Support Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Percutaneous Mechanical Circulatory Support Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Percutaneous Mechanical Circulatory Support Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Percutaneous Mechanical Circulatory Support Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Percutaneous Mechanical Circulatory Support Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Percutaneous Mechanical Circulatory Support Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Percutaneous Mechanical Circulatory Support Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Percutaneous Mechanical Circulatory Support Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Percutaneous Mechanical Circulatory Support Devices Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Percutaneous Mechanical Circulatory Support Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Percutaneous Mechanical Circulatory Support Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Percutaneous Mechanical Circulatory Support Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Percutaneous Mechanical Circulatory Support Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Percutaneous Mechanical Circulatory Support Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Percutaneous Mechanical Circulatory Support Devices Market Competition by Key Manufacturers

9.1. Global Percutaneous Mechanical Circulatory Support Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Percutaneous Mechanical Circulatory Support Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Medtronic

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Abbott Laboratories

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. LivaNova

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Eurosets

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Jarvik Heart

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Cardiobridge

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Getinge AB

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. ABIOMED

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Teleflex Incorporated

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Berlin Heart

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Percutaneous Mechanical Circulatory Support Devices Market

Figure 4: Global Percutaneous Mechanical Circulatory Support Devices Market: Drivers

Figure 5: Global Percutaneous Mechanical Circulatory Support Devices Market: Challenges

Figure 6: Global Percutaneous Mechanical Circulatory Support Devices Market: Trends

Figure 7: Global Percutaneous Mechanical Circulatory Support Devices Market: Opportunity

Figure 8: Global Percutaneous Mechanical Circulatory Support Devices Market: Restraint

Figure 9: Global Percutaneous Mechanical Circulatory Support Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Percutaneous Mechanical Circulatory Support Devices Market Value (USD Million) By Region

Figure 19: Global Percutaneous Mechanical Circulatory Support Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Percutaneous Mechanical Circulatory Support Devices Market Value (USD Million) By Region

Figure 27: Global Percutaneous Mechanical Circulatory Support Devices Market Share (%) By: Regions (2032)

Figure 28: Global Percutaneous Mechanical Circulatory Support Devices Market Volume (K) By Region

Figure 29: Global Percutaneous Mechanical Circulatory Support Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Percutaneous Mechanical Circulatory Support Devices Market Value (USD Million) By Region

Figure 37: Global Percutaneous Mechanical Circulatory Support Devices Market Share (%) By: Regions (2032)

Figure 38: Global Percutaneous Mechanical Circulatory Support Devices Market Volume (K) By Region

Figure 39: Global Percutaneous Mechanical Circulatory Support Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Percutaneous Mechanical Circulatory Support Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Percutaneous Mechanical Circulatory Support Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Percutaneous Mechanical Circulatory Support Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Percutaneous Mechanical Circulatory Support Devices Market Value (USD Million) By Region

Table 14: Global Percutaneous Mechanical Circulatory Support Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Percutaneous Mechanical Circulatory Support Devices Market Volume (K) By Region

Table 31: Global Percutaneous Mechanical Circulatory Support Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Percutaneous Mechanical Circulatory Support Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Percutaneous Mechanical Circulatory Support Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Percutaneous Mechanical Circulatory Support Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Medtronic Basic Information And Sales Area

Table 52: Medtronic. Products Portfolio

Table 53: Abbott Laboratories Basic Information And Sales Area

Table 54: Abbott Laboratories. Products Portfolio

Table 55: LivaNova Basic Information And Sales Area

Table 56: LivaNova. Products Portfolio

Table 57: Eurosets Basic Information And Sales Area

Table 58: Eurosets. Products Portfolio

Table 59: Jarvik Heart Basic Information And Sales Area

Table 60: Jarvik Heart. Products Portfolio

Table 61: Cardiobridge Basic Information And Sales Area

Table 62: Cardiobridge. Products Portfolio

Table 63: Getinge AB Basic Information And Sales Area

Table 64: Getinge AB. Products Portfolio

Table 65: ABIOMED Basic Information And Sales Area

Table 66: ABIOMED. Products Portfolio

Table 67: Teleflex Incorporated Basic Information And Sales Area

Table 68: Teleflex Incorporated. Products Portfolio

Table 69: Berlin Heart Basic Information And Sales Area

Table 70: Berlin Heart. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Percutaneous Mechanical Circulatory Support Devices Market Value (USD Million) By Region

Table 80: Global Percutaneous Mechanical Circulatory Support Devices Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Percutaneous Mechanical Circulatory Support Devices Market Volume (K) By Region

Table 97: Global Percutaneous Mechanical Circulatory Support Devices Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

FAQs

1. What is the current Percutaneous Mechanical Circulatory Support Devices market size?

The Percutaneous Mechanical Circulatory Support Devices market size reached approximately USD 1.15 billion in 2023, driven by rising acute heart failure cases and expanding catheter‑based therapy adoption across North America and Europe. This baseline underpins projected growth through 2032.

2. What is the forecasted compound annual growth rate and market value by 2032?

Analysts project a CAGR of 6.2 % for the Percutaneous Mechanical Circulatory Support Devices market from 2024 to 2032, lifting the market value to roughly USD 2.3 billion by the end of the forecast horizon, outpacing many adjacent cardiac segments.

3. Which key drivers are accelerating market expansion?

Key drivers include increasing prevalence of cardiogenic shock, rapid adoption of minimally invasive procedures, reimbursement reforms favoring percutaneous therapies, and technological advances that improve device durability and ease of implantation, all fueling higher procedure volumes worldwide.

4. What challenges could hinder market growth?

Challenges comprise high upfront device costs, limited long‑term outcome data, and procedural complications such as vascular injury, and stringent regulatory pathways that lengthen time‑to‑market, potentially restraining adoption in cost‑sensitive healthcare systems. Furthermore, physician training gaps and competition from emerging ventricular assist technologies add further pressure.

5. Which regions currently lead the market and why?

North America remains the dominant region, accounting for over 45 % of revenue, due to high device reimbursement rates and advanced hospital networks. Europe follows, propelled by strong clinical trial activity, while Asia‑Pacific shows rapid growth driven by expanding cardiac care infrastructure.

6. Who are the top companies competing in this market?

Leading players include Abbott Laboratories, Medtronic plc, Boston Scientific, Edwards Lifesciences, and Impulse Dynamics, each offering distinct Impella, TandemHeart, and other catheter‑based platforms. These firms compete on device performance, portfolio breadth, and strategic partnerships with high‑volume cardiac centers.

7. What future opportunities are emerging for market participants?

Future opportunities arise from integration of real‑time hemodynamic monitoring, development of fully percutaneous ventricular assist systems, and expansion into emergent settings such as pre‑hospital cardiac arrest care. Partnerships with AI analytics firms may also unlock predictive maintenance and patient selection tools.

8. How is technology influencing the market’s future outlook?

Advances in miniaturized pump designs, magnetic‑levitation bearings, and bio‑compatible materials are reducing complication rates and enabling longer support durations, which strengthens the future outlook for Percutaneous Mechanical Circulatory Support Devices market size by attracting broader clinical indications and reimbursement acceptance.

9. What is the current regulatory landscape affecting product launch?

Regulatory pathways vary globally; in the United States, devices require FDA 510(k) clearance or PMA approval, while Europe follows the MDR conformity assessment. Emerging markets are tightening standards, demanding robust clinical evidence, which can extend development timelines.

Contact for Full Report

Loading report content...

Percutaneous Mechanical Circulatory Support Devices Market 2026: Primary Research + Expert Analysis

Market Snapshot

Percutaneous Mechanical Circulatory Support Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Percutaneous Mechanical Circulatory Support Devices Segmentation

Percutaneous Mechanical Circulatory Support Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Percutaneous Mechanical Circulatory Support Devices market size?

2. What is the forecasted compound annual growth rate and market value by 2032?

3. Which key drivers are accelerating market expansion?

4. What challenges could hinder market growth?

5. Which regions currently lead the market and why?

6. Who are the top companies competing in this market?

7. What future opportunities are emerging for market participants?

8. How is technology influencing the market’s future outlook?

9. What is the current regulatory landscape affecting product launch?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Percutaneous Mechanical Circulatory Support Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Percutaneous Mechanical Circulatory Support Devices Segmentation

Percutaneous Mechanical Circulatory Support Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Percutaneous Mechanical Circulatory Support Devices market size?

2. What is the forecasted compound annual growth rate and market value by 2032?

3. Which key drivers are accelerating market expansion?

4. What challenges could hinder market growth?

5. Which regions currently lead the market and why?

6. Who are the top companies competing in this market?

7. What future opportunities are emerging for market participants?

8. How is technology influencing the market’s future outlook?

9. What is the current regulatory landscape affecting product launch?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation